Tumor Necrosis Factor Receptor Superfamily, Member 8 Proteins (TNFRSF8)

The protein encoded by TNFRSF8 is a member of the TNF-receptor superfamily.

list all proteins Gene Name GeneID UniProt
Human TNFRSF8 TNFRSF8 943 P28908
Mouse TNFRSF8 TNFRSF8 21941 Q60846
Rat TNFRSF8 TNFRSF8 25069 P97525
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top TNFRSF8 Proteins at antibodies-online.com

Showing 10 out of 29 products:

Catalog No. Origin Source Conjugate Images Quantity Supplier Delivery Price Details
HEK-293 Cells Human His tag 50 μg Log in to see 2 to 3 Days
$595.00
Details
Insect Cells Mouse rho-1D4 tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 0.25 mg Log in to see 50 to 55 Days
$4,649.05
Details
Insect Cells Human His tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 1 mg Log in to see 50 Days
$5,960.83
Details
HEK-293 Cells Human His tag 100 μg Log in to see 2 to 3 Days
$286.00
Details
Human Cells Human His tag 100 μg Log in to see 20 to 21 Days
$272.80
Details
HEK-293 Cells Human Fc Tag 100 μg Log in to see 11 Days
$286.00
Details
HEK-293 Cells Human Myc-DYKDDDDK Tag Validation with Western Blot 20 μg Log in to see Available
$814.00
Details
Insect cells (Sf9) Human DYKDDDDK Tag Validation with Western Blot 20 μg Log in to see Available
$504.90
Details
Escherichia coli (E. coli) Human His tag 50 μg Log in to see 15 to 19 Days
$400.00
Details
Wheat germ Human GST tag 10 μg Log in to see 11 to 12 Days
$414.29
Details

More Proteins for Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) Interaction Partners

Human Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) interaction partners

  1. Data suggest that CD4 (show CD4 Proteins)+ T cell-associated HIV-1 RNA is often highly enriched in cells expressing CD30; cells expressing this marker considerably contribute to total pool of transcriptionally active CD4 (show CD4 Proteins)+ lymphocytes in individuals on suppressive anti-retroviral drug therapy; CD30 may be a marker of residual, transcriptionally active HIV-1 infected cells in blood and in gut (show GUSB Proteins)-associated lymphoid tissue.

  2. The stable elevation in classical Hodgkin lymphoma risk with elevated levels of sCD30 and IL6 (show IL6 Proteins) across 4 or more years prior to diagnosis may also reflect a B-cell-stimulatory environment that promotes the genesis of these cancers.

  3. extranodal NK/T-cell lymphoma, nasal type(ENKTL) is the most common type of mature T-cell and NK-cell lymphoma diagnosed at our institution. CD30 is frequently expressed in ENKTL and represents a therapeutic target; however, it may not be a prognostic marker.

  4. This study suggests that in patients with CD30+ lymphoproliferative disorders, an aggressive clinical course cannot be defined by the presence of TP63 rearrangements, as was recently shown in systemic ALK negative anaplastic large cell lymphoma.

  5. Data suggest that Brentuximab Vedotin (SGN-35) damaged CD30 ligand (CD30L (show TNFSF8 Proteins))-immune cells through CD30 extracellular vesicles (EVs).

  6. median FoxP3 (show FOXP3 Proteins)+ Treg count was higher in CD30+ than in CD30- posttransplant lymphoproliferative disorders, 3.0 vs 0

  7. Variant histology is common in pediatric NLPHL, especially types C and E, which are associated with IgD expression. Type C variant histology and possibly type D are associated with decreased EFS (show EFS Proteins), but neither IgD nor CD30 are adverse features. Variant histology may warrant increased surveillance, but did not affect overall survival.

  8. Expression of CD30 in patients with both DLBCL and other aggressive B-cell lymphomas and the absence of MYC (show MYC Proteins) oncogene (show RAB1A Proteins)-driven proliferation in the majority of these tumors suggests that brentuximab may be a particularly effective form of targeted therapy in the subset of patients with high CD30 expression.

  9. Prevalence of the CD30 (Ki-1) antigen in human solid tumors was summarized.

  10. CD30 expression was detected in up to 25% of cases of diffuse large B-cell lymphoma and was more frequent in tumors without MYC (show MYC Proteins) rearrangement. CD30 expression was not associated with overall survival in R-EPOCH-treated de novo DLBCL patients.

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) interaction partners

  1. This study demonstrated the amelioration of MOG35-55 peptide-induced active EAE in CD30 KO mice. CD30 was expressed limitedly on CD4 (show CD4 Proteins) T cells at the induction phase of experimental autoimmune encephalomyelitis.

  2. Data indicate that CD30L (show TNFSF8 Proteins)/CD30 axis plays a modulatory role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE).

  3. role in the maintenance and activation of IL-17A (show IL17A Proteins)-producing gammadelta T cells

  4. These results suggest that CD30 signaling plays an important role in the activation of IL-17A (show IL17A Proteins)-producing Vgamma1(-) Vgamma4(-) gammadelta T cells bearing Vgamma6 at an early stage of BCG (show SLC11A1 Proteins) infection.

  5. Interference of the CD30-CD30L (show TNFSF8 Proteins) pathway reduces atherosclerosis development.

  6. CD30L (show TNFSF8 Proteins)/CD30 pathway acts as an accelerator of enteritis in a murine disease model

  7. role of CD30L (show TNFSF8 Proteins)/CD30 interactions in allergic rhinitis; results suggest that CD30L (show TNFSF8 Proteins) plays an important role in allergic rhinitis

  8. Abrogation of CD30 and OX40 (show TNFRSF4 Proteins) signals prevents autoimmune disease in FoxP3 (show FOXP3 Proteins)-deficient mice.

  9. Studies demonstrate that CD30L (show TNFSF8 Proteins)/CD30 signaling executed by the T-T cell interaction plays a critical role in Th17 cell differentiation.

  10. CD30 can signal in a completely TCR-independent fashion to induce IL-13 (show IL13 Proteins) production by effector T cells.

TNFRSF8 Protein Profile

Protein Summary

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.

Gene names and symbols associated with TNFRSF8

  • TNF receptor superfamily member 8 (TNFRSF8)
  • tumor necrosis factor receptor superfamily, member 8 (Tnfrsf8)
  • TNF receptor superfamily member 8 (Tnfrsf8)
  • Cd30 protein
  • D1S166E protein
  • Ki protein
  • Ki-1 protein
  • TNFRSF8 protein

Protein level used designations for TNFRSF8

CD30L receptor , Ki-1 antigen , cytokine receptor CD30 , lymphocyte activation antigen CD30 , tumor necrosis factor receptor superfamily member 8 , Tumor necrosis factor superfamily member 8 , tumor necrosis factor superfamily, member CD30 , tumor necrosis factor receptor superfamily, member 8 , tumor necrosis factor receptor superfamily member 8-like

GENE ID SPECIES
943 Homo sapiens
21941 Mus musculus
25069 Rattus norvegicus
395090 Gallus gallus
457960 Pan troglodytes
487438 Canis lupus familiaris
614780 Bos taurus
722773 Macaca mulatta
100385465 Callithrix jacchus
100579424 Nomascus leucogenys
Did you look for something else?